linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 Company News  
Emcure Pharmaceuticals Ltd.
 
BSE Code 544210
ISIN Demat INE168P01015
Book Value 169.51
NSE Code EMCURE
Dividend Yield % 0.22
Market Cap 262254.66
P/E 60.97
EPS 22.69
Face Value 10  
27-Nov-2025 Emcure Pharmaceuticals informs about disclosure
22-Nov-2025 Emcure Pharmaceuticals informs about resignation ...
19-Nov-2025 Emcure Pharmaceuticals informs about investor pr...
10-Nov-2025 Emcure Pharma, Novo Nordisk India join hands to l...
06-Oct-2025 Emcure Pharmaceuticals surges on acquiring 20.42%...
04-Oct-2025 Emcure Pharmaceuticals acquires 20.42% stake in Z...
07-Aug-2025 Emcure Pharmaceuticals informs about outcome of b...
17-Jul-2025 Emcure Pharmaceuticals enters into agreement with...
17-Jul-2025 Emcure Pharmaceuticals gains on entering into agr...
10-Jul-2025 USFDA concludes PAI at Emcure Pharmaceuticals’ Gu...
04-Jul-2025 Emcure Pharmaceuticals incorporates wholly owned ...
04-Jul-2025 Emcure Pharmaceuticals informs about incorporatio...
23-Jun-2025 Emcure Pharmaceuticals jumps on getting nod for a...
21-Jun-2025 Emcure Pharmaceuticals gets nod for acquiring 20....
21-Jun-2025 Emcure Pharmaceuticals gets nod to incorporate wh...
Page 1 of 3
Prev || Next
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.